Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-28T00:19:34.402Z Has data issue: false hasContentIssue false
  • English
  • Français

Reply to Daniell

Published online by Cambridge University Press:  10 May 2016

Courtney Hebert  and
Ari Robicsek
Courtney Hebert*
Affiliation:
Departments of Biomedical Informatics and Division of Infectious Diseases, Ohio State University Wexner Medical Center, Columbus, Ohio
Ari Robicsek
Affiliation:
Departments of Medicine and Health Information Technology, NorthShore University HealthSystem, Evanston, Illinois; and Pritzker School of Medicine, University of Chicago, Chicago, Illinois
*
Division of Infectious Diseases, Ohio State University Wexner Medical Center, 3190 Graves Hall, 333 West Tenth Avenue, Columbus, OH 43210 ([email protected])
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 35 , Issue 1 , January 2014 , pp. 94 - 95
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2014

References

1. Danieli, HW. Increased Clostridium difficile recurrences following combined proton pump inhibitor-metronidazole therapy. Infect Control Hosp Epidemiol 2014;35:94 (in this issue).Google Scholar
2. Hebert, C, Du, H, Peterson, LR, Robicsek, A. Electronic health record-based detection of risk factors for Clostridium difficile infection relapse. Infect Control Hosp Epidemiol 2013;34:407–414.CrossRefGoogle ScholarPubMed